Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MOLINA HEALTHCARE, INC.

(MOH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 7 2518 50812 61216 41316 413-
Enterprise Value (EV)1 4 2025 3658 71013 43912 03710 509
P/E ratio 11,0x11,8x18,9x23,0x17,5x15,3x
Yield ------
Capitalization / Revenue 0,38x0,51x0,65x0,60x0,54x0,51x
EV / Revenue 0,22x0,32x0,45x0,49x0,39x0,33x
EV / EBITDA 3,42x4,67x6,55x11,1x7,95x6,18x
Price to Book 4,38x4,29x5,99x6,00x4,07x2,98x
Nbr of stocks (in thousands) 62 38962 70059 30058 40058 400-
Reference price (USD) 116136213281281281
Announcement Date 02/11/201902/10/202002/10/2021---
1 USD in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 18 89016 82919 42327 44030 53232 300
EBITDA1 1 2301 1481 3301 2131 5151 702
Operating profit (EBIT)1 1 1311 0441 2421 0921 3861 572
Operating Margin 5,99%6,20%6,39%3,98%4,54%4,87%
Pre-Tax Profit (EBT)1 9999729619591 2611 442
Net income1 7077376737149291 040
Net margin 3,74%4,38%3,46%2,60%3,04%3,22%
EPS2 10,611,511,212,216,118,4
Dividend per Share2 ------
Announcement Date 02/11/201902/10/202002/10/2021---
1 USD in Million
2 USD
Previous periodNext period
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2
Net sales1 6 5226 8007 0407 1907 6477 654
EBITDA1 398310270258430384
Operating profit (EBIT)1 365279238224408363
Operating Margin 5,60%4,10%3,38%3,12%5,34%4,74%
Pre-Tax Profit (EBT)1 305243191201359328
Net income1 228185143147275243
Net margin 3,50%2,72%2,03%2,05%3,60%3,17%
EPS2 3,893,162,462,494,724,17
Dividend per Share ------
Announcement Date 04/28/202107/28/202110/27/2021---
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 ------
Net Cash position1 3 0493 1433 9022 9744 3765 904
Leverage (Debt / EBITDA) -2,48x-2,74x-2,93x-2,45x-2,89x-3,47x
Free Cash Flow1 -3443701 8161 4281 4321 077
ROE (Net Profit / Equities) 47,4%40,9%33,2%30,3%28,9%25,2%
Shareholders' equity1 1 4921 8032 0282 3543 2164 124
ROA (Net Profit / Asset) 9,05%10,6%8,25%7,52%7,94%7,84%
Assets1 7 8136 9718 1599 49611 70513 261
Book Value Per Share2 26,631,635,546,969,094,3
Cash Flow per Share2 -4,716,65-29,124,422,8
Capex1 30,057,074,074,679,279,8
Capex / Sales 0,16%0,34%0,38%0,27%0,26%0,25%
Announcement Date 02/11/201902/10/202002/10/2021---
1 USD in Million
2 USD
Previous periodNext period
Key data
Capitalization (USD) 16 413 320 000
Net sales (USD) 19 423 000 000
Number of employees 10 500
Sales / Employee (USD) 1 849 810
Free-Float 99,1%
Free-Float capitalization (USD) 16 273 358 786
Avg. Exchange 20 sessions (USD) 70 417 921
Average Daily Capital Traded 0,43%
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA